Search research articles
Contact Us
Filters
Showing results (121-130 of 146) with videos related to
Page
of 15
Sort By:
Organic Letters
|
March 8, 2016
A Synthesis of a Spirocyclic Macrocyclic Protease Inhibitor for the Treatment of Hepatitis C
Cheol K Chung, Ed Cleator, Aaron M Dumas, et al.
Veterinary Dermatology
|
December 16, 2015
IL-31-induced pruritus in dogs: a novel experimental model to evaluate anti-pruritic effects of canine therapeutics
Andrea J Gonzales, Timothy J Fleck, William R Humphrey, et al.
Investigational New Drugs
|
September 1, 2005
An NCIC-CTG phase I dose escalation pharmacokinetic study of the matrix metalloproteinase inhibitor BAY 12-9566 in combination with doxorubicin
H Hirte, D Stewart, R Goel, et al.
Pharmacoepidemiology and Drug Safety
|
January 30, 2013
Safe lists for medications in pregnancy: inadequate evidence base and inconsistent guidance from Web-based information, 2011
Stacey L Peters, Jennifer N Lind, Jasmine R Humphrey, et al.
American Journal of Epidemiology
|
April 3, 1998
Prevalence and risk factors for diabetic retinopathy in the multiethnic population of Mauritius
G K Dowse, A R Humphrey, V R Collins, et al.
The Journal of Allergy and Clinical Immunology
|
April 17, 2025
Baseline basophil activation and early suppression is associated with clinical outcome after peanut sublingual immunotherapy
Jessica R Humphrey, Rishu Guo, Xiaohong Yue, et al.
Chemical Science
|
September 14, 2018
Combining traditional 2D and modern physical organic-derived descriptors to predict enhanced enantioselectivity for the key aza-Michael conjugate addition in the synthesis of Prevymis™ (letermovir)
Toni T Metsänen, Katrina W Lexa, Celine B Santiago, et al.
Investigational New Drugs
|
November 6, 2004
An NCIC CTG phase I/pharmacokinetic study of the matrix metalloproteinase and angiogenesis inhibitor BAY 12-9566 in combination with 5-fluorouracil/leucovorin
R Goel, E Chouinard, D J Stewart, et al.
Journal of Medicinal Chemistry
|
July 9, 1993
Synthesis and biological evaluation of antiplatelet 2-aminochromones
J Morris, D G Wishka, A H Lin, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 7, 2000
Phase I and pharmacologic study of the specific matrix metalloproteinase inhibitor BAY 12-9566 on a protracted oral daily dosing schedule in patients with solid malignancies
E K Rowinsky, R Humphrey, L A Hammond, et al.
Page
of 15
Search research articles
Search
Showing results (121-130 of 146) with videos related to
Sort By:
Page
of 15
Organic Letters
|
March 8, 2016
A Synthesis of a Spirocyclic Macrocyclic Protease Inhibitor for the Treatment of Hepatitis C
Cheol K Chung, Ed Cleator, Aaron M Dumas, et al.
Veterinary Dermatology
|
December 16, 2015
IL-31-induced pruritus in dogs: a novel experimental model to evaluate anti-pruritic effects of canine therapeutics
Andrea J Gonzales, Timothy J Fleck, William R Humphrey, et al.
Investigational New Drugs
|
September 1, 2005
An NCIC-CTG phase I dose escalation pharmacokinetic study of the matrix metalloproteinase inhibitor BAY 12-9566 in combination with doxorubicin
H Hirte, D Stewart, R Goel, et al.
Pharmacoepidemiology and Drug Safety
|
January 30, 2013
Safe lists for medications in pregnancy: inadequate evidence base and inconsistent guidance from Web-based information, 2011
Stacey L Peters, Jennifer N Lind, Jasmine R Humphrey, et al.
American Journal of Epidemiology
|
April 3, 1998
Prevalence and risk factors for diabetic retinopathy in the multiethnic population of Mauritius
G K Dowse, A R Humphrey, V R Collins, et al.
The Journal of Allergy and Clinical Immunology
|
April 17, 2025
Baseline basophil activation and early suppression is associated with clinical outcome after peanut sublingual immunotherapy
Jessica R Humphrey, Rishu Guo, Xiaohong Yue, et al.
Chemical Science
|
September 14, 2018
Combining traditional 2D and modern physical organic-derived descriptors to predict enhanced enantioselectivity for the key aza-Michael conjugate addition in the synthesis of Prevymis™ (letermovir)
Toni T Metsänen, Katrina W Lexa, Celine B Santiago, et al.
Investigational New Drugs
|
November 6, 2004
An NCIC CTG phase I/pharmacokinetic study of the matrix metalloproteinase and angiogenesis inhibitor BAY 12-9566 in combination with 5-fluorouracil/leucovorin
R Goel, E Chouinard, D J Stewart, et al.
Journal of Medicinal Chemistry
|
July 9, 1993
Synthesis and biological evaluation of antiplatelet 2-aminochromones
J Morris, D G Wishka, A H Lin, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 7, 2000
Phase I and pharmacologic study of the specific matrix metalloproteinase inhibitor BAY 12-9566 on a protracted oral daily dosing schedule in patients with solid malignancies
E K Rowinsky, R Humphrey, L A Hammond, et al.
Page
of 15